MEDICINOVA, INC. (MNOV)

1.44 +1.41% (+0.02)

Over 5Y: -60.4%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

1 2 3 4
2021 2022 2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 37.5K Q3 '21 — Operating Income: -3.6M Q3 '21 — Free Cash Flow: -3M Q3 '21 — Net Income: -3.6M Q4 '21 — Revenue: 0 Q4 '21 — Operating Income: -2.1M Q4 '21 — Free Cash Flow: -3.6M Q4 '21 — Net Income: -2.1M Q1 '22 — Operating Income: -3.4M Q1 '22 — Net Income: -3.4M Q2 '22 — Operating Income: -4.1M Q2 '22 — Net Income: -4M Q3 '22 — Operating Income: -3.9M Q3 '22 — Net Income: -3.7M Q4 '22 — Operating Income: -3.2M Q4 '22 — Net Income: -3M Q1 '23 — Operating Income: -3M Q1 '23 — Net Income: -2.9M Q2 '23 — Operating Income: -3.3M Q2 '23 — Net Income: -2.9M Q3 '23 — Revenue: 1M Q3 '23 — Operating Income: -1.1M Q3 '23 — Free Cash Flow: -1.4M Q3 '23 — Net Income: -723.1K Q4 '23 — Revenue: 0 Q4 '23 — Operating Income: -2.5M Q4 '23 — Free Cash Flow: -499.1K Q4 '23 — Net Income: -2.1M Q1 '24 — Operating Income: -3.1M Q1 '24 — Net Income: -2.8M Q2 '24 — Operating Income: -3M Q2 '24 — Net Income: -2.6M Q3 '24 — Operating Income: -3.3M Q3 '24 — Free Cash Flow: -2M Q3 '24 — Net Income: -2.9M Q4 '24 — Operating Income: -3.2M Q4 '24 — Free Cash Flow: -1.9M Q4 '24 — Net Income: -2.8M Q1 '25 — Operating Income: -3.2M Q1 '25 — Free Cash Flow: -3.8M Q1 '25 — Net Income: -2.9M Q2 '25 — Revenue: 134.6K Q2 '25 — Operating Income: -3.6M Q2 '25 — Free Cash Flow: -2.3M Q2 '25 — Net Income: -3.3M Q3 '25 — Revenue: 123.3K Q3 '25 — Operating Income: -3.4M Q3 '25 — Free Cash Flow: -1.7M Q3 '25 — Net Income: -3.1M Q4 '25 — Revenue: 151.7K Q4 '25 — Operating Income: -3.1M Q4 '25 — Free Cash Flow: -2M Q4 '25 — Net Income: -2.8M Q1 '26 — Revenue: 187K Q1 '26 — Operating Income: -2.8M Q1 '26 — Free Cash Flow: -3.5M Q1 '26 — Net Income: -2.6M Q2 '26 — Revenue: 458.4K Q2 '26 — Operating Income: -2.5M Q2 '26 — Free Cash Flow: -1.9M Q2 '26 — Net Income: -2.3M -3M -1.5M 0 1.5M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Income Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 100.3%
OE margin -1091.5%
Oper. margin -1287.4%
Accruals -4.1%
Asset turnover 0.023×
EBITDA margin -1285.3%
FCF margin -991.2%
OCF margin -989.7%
Profit margin -1168.2%
ROA -26.6%
ROCE -31.6%
ROE -28.9%
Gross margin —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 2.0×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.3
ND/EBITDA —
Cash runway 7.2 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 8.8×
F-score 1.3 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.4
Sales Q/Q +240.6%
Shares change +0.035%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales/sh Y/Y —

2 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.